SCHEMBL7418258

SCHEMBL7418258

Fc1ccc(NC(c2ccc(F)cc2)C2CCCN(CCCOc3ccccc3)C2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.46
HTR1A P08908 2/20 0.46
DRD2 P14416 2/20 0.46
HTR7 P34969 1/20 0.46
HTR6 P50406 1/20 0.46
HRH2 P25021 1/20 0.45
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
SLC6A3 Q01959 1/20 0.45
HTR2A P28223 1/20 0.44
HRH1 P35367 1/20 0.44
DRD3 P35462 1/20 0.44
TMEM97 Q5BJF2 1/20 0.44
SIGMAR1 Q99720 1/20 0.44
CACNA1B Q00975 3/20 0.44
CACNA1H O95180 1/20 0.43
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7412531 0.94 DRD2 (0.47) HTR1ADRD2HTR7HTR6SLC6A3
SCHEMBL7410875 0.88 DRD2 (0.50) HRH3HTR1ADRD2HTR7HRH2
Hydrochloric Acid SCHEMBL7413705 0.86 DRD2 (0.48) HTR1ADRD2HTR7SLC6A3HTR2A
Hydrochloric Acid SCHEMBL7413702 0.86 DRD2 (0.48) HTR1ADRD2HTR7SLC6A3HTR2A
SCHEMBL7409358 0.82 EPHX2 (0.41) HRH3HTR1ADRD2HTR7HTR6
SCHEMBL7414683 0.82 SLC6A3 (0.46) HRH3HTR1ADRD2HTR7HRH2
SCHEMBL7415382 0.80 DRD2 (0.47) HTR1ADRD2HTR7SLC6A3HTR2A
SCHEMBL7404666 0.79 SLC6A3 (0.47) HRH3HTR1ADRD2HTR7HTR6
SCHEMBL7407159 0.79 DRD2 (0.47) HTR1ADRD2HTR7SLC6A3HTR2A
SCHEMBL7416352 0.79 SLC6A3 (0.45) HRH3HTR1ADRD2HRH2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5198449-A N-substituted alpha-arylazacycloalkylmethanamines and their use as cardiovascular agents A. H. ROBINS COMPANY INCORPORATED (US) 1993-03-30 US disclosed